Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024
DOI: 10.1161/atvbaha.123.320185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Indranil Biswas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation (I.B., H.G., S.R.P., A.R.R.). Hauptthemen laut MEDLINE: Receptor, PAR-1, Thrombin. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Cleavage of the extracellular domain of PAR1 (protease-activated receptor 1) by thrombin at Arg41 and by APC (activated protein C) at Arg46 initiates paradoxical cytopathic and cytoprotective signaling in endothelial cells. In the latter case, the ligand-dependent coreceptor signaling by EPCR (endothelial protein C receptor) is required for the protective PAR1 signaling by APC. Here, we investigated the role of thrombomodulin in determining the specificity of PAR1 signaling by thrombin. METHODS: We prepared a PAR1 knockout (PAR1 −/− ) EA.hy926 endothelial cell line by CRISPR/Cas9 and transduced PAR1 −/− cells with lentivirus vectors expressing PAR1 mutants in which either Arg41 or Arg46 was replaced with an Ala. Furthermore, human embryonic kidney 293 cells were transfected with wild-type or mutant PAR1 cleavage reporter constructs carrying N-terminal Nluc (NanoLuc luciferase) and C-terminal enhanced yellow fluorescent protein tags. RESULTS: Characterization of transfected cells in signaling and receptor cleavage assays revealed that, upon interaction with thrombomodulin, thrombin cleaves Arg46 to elicit cytoprotective effects by a β-arrestin-2 biased signaling mechanism. Analysis of functional data and cleavage rates indicated that thrombin-thrombomodulin cleaves Arg46>10-fold faster than APC. Upon interaction with thrombin, the cytoplasmic domain of thrombomodulin recruited both β-arrestin-1 and -2 to the plasma membrane. Thus, the thrombin cleavage of Arg41 was also cytoprotective in thrombomodulin-expressing cells by β-arrestin-1-biased signaling. APC in the absence of EPCR cleaved Arg41 to initiate disruptive signaling responses like thrombin. CONCLUSIONS: These results suggest that coreceptor signaling by thrombomodulin and EPCR determines the PAR1 cleavage and signaling specificity of thrombin and APC, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation (I.B., H.G., S.R.P., A.R.R.).
- Now with Excitant Therapeutics, Edmond, OK (H.G.).
- Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City (A.R.R.).
ORCID-Profile: Hemant Giri, Sumith R Panicker, Alireza R Rezaie
Förderung
- NHLBI NIH HHS
Zitieren
APA
Biswas, I., Giri, H., Panicker, S. R., & Rezaie, A. R. (2024). Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.123.320185
Vancouver
Biswas I, Giri H, Panicker SR, Rezaie AR. Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.123.320185
BibTeX
@article{Biswas2024,
author = {Biswas, Indranil and Giri, Hemant and Panicker, Sumith R and Rezaie, Alireza R},
title = {Thrombomodulin Switches Signaling and Protease-Activated Receptor 1 Cleavage Specificity of Thrombin},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
doi = {10.1161/atvbaha.123.320185}
}
EUVIMED